Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

COVID-19 Antibody Test Released by Ortho Clinical Diagnostics

RARITAN, New Jersey, April 4, 2020 /PRNewswire/ -- Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 To...

2020-04-04 07:06 2756

COVID-19 Antibody Test Released by Ortho Clinical Diagnostics

Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China

GERMANTOWN, Maryland, April 3, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced the completion of its new cell manufacturing facility in Suzhou,China. The facilit...

2020-04-03 20:00 2364

CPhI & P-MEC China 2020 will join hands with P-Logi China 2020 and be held at Shanghai New International Expo Center in June

SHANGHAI, April 3, 2020 /PRNewswire/ -- To provide global vision and opportunities for the intelligent coordination between pharmaceutical enterprises and logistics service and equipment suppliers, P-Logi China 2020, organized by Informa Markets and CCCMHPIE and co-organized by Sinoexpo Informa ...

2020-04-03 17:02 2759

CPhI & P-MEC China 2020 will join hands with P-Logi China 2020 and be held at Shanghai New International Expo Center in June

CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality

SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...

2020-04-03 09:12 4769

China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

-- XEN® Becomes the First Medical Product Approved by Using Real World Evidence inChina -- DUBLIN, April 2, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel Stent on March 26, 202...

2020-04-02 19:30 7541

Covid-19 Related Delays in the Ongoing Phase IIb-study are Expected to be Managed With Existing Funding

STOCKHOLM, April 2, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onApril 2 2020, that the company is now seeing signs of delays in the ongoing clinical phase IIb study with the drug candidate RV001 in prostate cancer, due to the Covid-19 pandemic. However, the company believes that ...

2020-04-02 17:17 1418

Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020

HANGZHOU and SHAOXING, China, April 1, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate TVB-2640 (Ascl...

2020-04-01 08:30 2897

Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

BAGSVÆRD, Denmark, April 1, 2020 /PRNewswire/ -- Novo Nordisk today announced that theNew England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted for pr...

2020-04-01 00:00 1079

Yiling Pharmacy Lianhua Qingwen has been approved by the Ministry of Health of Thailand

SHIJIAZHUANG, China, March 31, 2020 /PRNewswire/ -- On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the ministry of health ofThailand. Lianhua Qingwen Capsule is recognized as in li...

2020-03-31 18:15 3038

Yuyu Pharma introduces new advanced ERP management system

SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making. The new ERP system took more...

2020-03-31 16:00 1332

Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group

SYDNEY, March 31, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O'Bryan-Tear will be chairing Clarity's newly formed Global Clinical Development group. Dr O'Bryan-Tear joined the pha...

2020-03-31 12:10 1371

INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia

PLYMOUTH MEETING, Pennsylvania, March 30, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) today reported interim results from an open-label Phase 2 trial designed to evaluate the safety and efficacy of VGX-3100 in women with vulvar dysplasia, also known as high grade squamous int...

2020-03-30 21:00 2853

OssDsign Receives Regulatory Approval and Prepares for Launch in Japan

STOCKHOLM, March 30, 2020 /PRNewswire/ -- OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market. OssDsign plans to launch OssDsign Cranial PSI inJapan together with a national dis...

2020-03-30 20:42 1661

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...

2020-03-30 19:32 4533

CSPC Pharmaceutical Announces 2019 Annual Results

Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the...

2020-03-30 12:34 3559

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial

NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment), announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...

2020-03-27 21:00 2784

Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg

TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...

2020-03-27 19:53 3898

INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia

- VGX-3100 DNA medicine cleared high-risk HPV 16/18-associated precancerous lesions in 50% of patients, and reduced the number of lesions in 75% of patients - Data to be presented at the 2020 American Society for Colposcopy and Cervical Pathology (ASCCP) meeting PLYMOUTH MEETING, Pa., March 26, ...

2020-03-26 21:00 3511

Nippon Express Receives GDP Certification for Temperature-controlled Facility in Narita Area

TOKYO, March 26, 2020 /PRNewswire/ -- Nippon Express Co., Ltd., has received Good Distribution Practice (GDP) certification indicating compliance with industry-accepted standards for the proper distribution of pharmaceutical products for its in-transit air cargo storage services at the Narita Te...

2020-03-26 15:00 2927

XABT donates 2019-nCoV nucleic acid detection kits to Italy

BEIJING, March 26, 2020 /PRNewswire/ -- On March 19, the 2019-nCoV Detection Kit and Nucleic Acid Extraction Donation & Shipment Ceremony was held inBeijing . Beijing Applied Biological Technologies Co., Ltd. (XABT) was invited to the event at which the biologics maker donated an allotment of nucl...

2020-03-26 10:14 5279

XABT donates 2019-nCoV nucleic acid detection kits to Italy

1 ... 176 177 178179180 181 182 ... 187